Abstract: A method of treating an infertility condition in humans or mammals, by exposure of a prospective mother to TGF beta or derivative or analog of TGF beta. The exposure is advantageously in conjunction with one more antigens of a prospective father so that a hyporesponsive immune reaction is mounted to the one or more antigens of the prospective father.
Type:
Grant
Filed:
March 6, 1998
Date of Patent:
April 17, 2007
Assignee:
The University of Adelaide
Inventors:
Sarah Anne Robertson, Kelton Paul Tremellen